Table 3B.
No. | Significant signaling pathways | Tnfr1,2-/- (GSE33253) | Ifng-/- (GSE9892) | Ifngr1-/- (GSE39592) | Il18-/- (GSE64309) |
---|---|---|---|---|---|
1 | Dendritic Cell Maturation | ↓ | ↓ | ↓ | ↓ |
2 | Cardiac Hypertrophy Signaling (Enhanced) | ↓ | ↓ | ↓ | |
3 | Systemic Lupus Erythematosus In B Cell Signaling Pathway | ↓ | ↓ | ↓ | |
4 | Interferon Signaling | ↓ | ↓ | ↓ | |
5 | Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses | ↓ | ↓ | ↓ | |
6 | TREM1 Signaling | ↓ | ↓ | ↓ | |
7 | Neuroinflammation Signaling Pathway | ↓ | ↓ | ↓ | |
8 | iNOS Signaling | ↓ | ↓ | ↓ | |
9 | p38 MAPK Signaling | ↓ | ↓ | ↓ | |
10 | Production of Nitric Oxide and Reactive Oxygen Species in Macrophages | ↓ | ↓ | ↓ | |
11 | Colorectal Cancer Metastasis Signaling | ↓ | ↓ | ↓ | |
12 | PI3K Signaling in B Lymphocytes | ↓ | ↓ | ↓ | |
13 | IL-1 Signaling | ↓ | ↓ | ↓ | |
14 | Adrenomedullin signaling pathway | ↓ | ↓ | ↓ | |
15 | Cholecystokinin/Gastrin-mediated Signaling | ↓ | ↓ | ↓ | |
16 | Toll-like Receptor Signaling | ↓ | ↓ | ↓ | |
17 | HGF Signaling | ↓ | ↓ | ||
18 | Tec Kinase Signaling | ↓ | ↓ | ||
19 | MIF Regulation of Innate Immunity | ↓ | ↓ | ||
20 | NF-κB Activation by Viruses | ↓ | ↓ | ||
21 | Signaling by Rho Family GTPases | ↓ | ↓ | ||
22 | ERK/MAPK Signaling | ↓ | ↓ | ||
23 | IL-8 Signaling | ↓ | ↓ | ||
24 | PI3K/AKT Signaling | ↓ | ↓ | ||
25 | PKCθ Signaling in T Lymphocytes | ↓ | ↓ | ||
26 | Endothelin-1 Signaling | ↓ | ↓ | ||
27 | Synaptogenesis Signaling Pathway | ↓ | ↓ | ||
28 | ILK Signaling | ↓ | ↓ | ||
29 | PDGF Signaling | ↓ | ↓ | ||
30 | Activation of IRF by Cytosolic Pattern Recognition Receptors | ↓ | ↓ | ||
31 | IL-6 Signaling | ↓ | ↓ | ||
32 | Th17 Activation Pathway | ↓ | ↓ | ||
33 | JAK/Stat Signaling | ↓ | ↓ | ||
34 | NF-κB Signaling | ↓ | ↓ | ||
35 | HMGB1 Signaling | ↓ | ↓ | ||
36 | Cardiac Hypertrophy Signaling | ↓ | ↓ | ||
37 | Acute Phase Response Signaling | ↓ | ↓ | ||
38 | Rac Signaling | ↓ | |||
39 | B Cell Receptor Signaling | ↓ | |||
40 | Ephrin Receptor Signaling | ↓ | |||
41 | Role of IL-17F in Allergic Inflammatory Airway Diseases | ↓ | |||
42 | PPAR Signaling | ↑ | |||
43 | Leukocyte Extravasation Signaling | ↓ | |||
44 | TNFR1 Signaling | ↓ | |||
45 | MIF-mediated Glucocorticoid Regulation | ↓ | |||
46 | Integrin Signaling | ↓ | |||
47 | RhoA Signaling | ↓ | |||
48 | Type II Diabetes Mellitus Signaling | ↓ | |||
49 | Cdc42 Signaling | ↓ | |||
50 | Antioxidant Action of Vitamin C | ↑ | |||
51 | iCOS-iCOSL Signaling in T Helper Cells | ↓ | |||
52 | FAT10 Cancer Signaling Pathway | ↓ | |||
53 | PAK Signaling | ↓ | |||
54 | Type I Diabetes Mellitus Signaling | ↓ | |||
55 | Renin-Angiotensin Signaling | ↓ | |||
56 | CD28 Signaling in T Helper Cells | ↓ | |||
57 | IL-7 Signaling Pathway | ↓ | |||
58 | LPS-stimulated MAPK Signaling | ↓ | |||
59 | Fc Epsilon RI Signaling | ↓ | |||
60 | cAMP-mediated signaling | ↓ | |||
61 | Osteoarthritis Pathway | ↓ | |||
62 | Hepatic Fibrosis Signaling Pathway | ↓ | |||
63 | T Cell Exhaustion Signaling Pathway | ↓ | |||
64 | Oncostatin M Signaling | ↓ | |||
65 | Unfolded protein response | ↓ | |||
66 | Retinoic acid Mediated Apoptosis Signaling | ↓ | |||
67 | LXR/RXR Activation | ↑ | |||
68 | Role of NFAT in Regulation of the Immune Response | ↓ | |||
69 | PPARα/RXRα Activation | ↑ | |||
70 | RhoGDI Signaling | ↑ |
A total of 10 microarrays about proinflammatory cytokines in Supplementary Table 2A were analyzed, GSE43145, GSE73875, GSE88800, GSE64309, GSE63761, GSE64308 and GSE64310 were not included because there were no significant (∣Z score∣< 2) pathways in them. The data showed a total of 37 shared significant signaling pathways of the down-regulated innate immune genes in the inflammatory cytokines KO microarrays. According to the IPA classification, 19 cellular immune response signals (marked in bold) are down-regulated by the PCs KO. And in 33 unique significant signaling pathways, 8 cellular immune response signals (marked in bold) were suppressed when one PCs was KO. The detailed IPA results were showed in Table S8 .